Analgesic Action of Invasive Carboxytherapy: Mechanisms and Applications

2021 ◽  
Author(s):  
N. M. Seredynska ◽  
S. M. Drogovoz ◽  
E. G. Shchokina ◽  
L. B. Ivantsyk ◽  
Yu. V. Stoletov ◽  
...  
Keyword(s):  
2005 ◽  
Vol 18 (2) ◽  
pp. 113
Author(s):  
Myung Ha Yoon ◽  
Hong Buem Bae ◽  
Jeong Il Choi ◽  
Seok Jae Kim ◽  
Chang Mo Kim ◽  
...  

2002 ◽  
Vol 87 (4) ◽  
pp. 1938-1947 ◽  
Author(s):  
Yu-Zhen Pan ◽  
De-Pei Li ◽  
Hui-Lin Pan

Activation of spinal α2-adrenergic receptors by the descending noradrenergic system and α2-adrenergic agonists produces analgesia. However, the sites and mechanisms of the analgesic action of spinally administered α2-adrenergic receptor agonists such as clonidine are not fully known. The dorsal horn neurons in the outer zone of lamina II (lamina IIo) are important for processing nociceptive information from C-fiber primary afferents. In the present study, we tested a hypothesis that activation of presynaptic α2-adrenergic receptors by clonidine inhibits the excitatory synaptic input to lamina IIo neurons. Whole cell voltage-clamp recordings were performed on visualized lamina IIo neurons in the spinal cord slice of rats. The miniature excitatory postsynaptic currents (mEPSCs) were recorded in the presence of tetrodotoxin, bicuculline, and strychnine. The evoked EPSCs were obtained by electrical stimulation of the dorsal root entry zone or the attached dorsal root. Both mEPSCs and evoked EPSCs were abolished by application of 6-cyano-7-nitroquinoxaline-2,3-dione. Clonidine (10 μM) significantly decreased the frequency of mEPSCs from 5.8 ± 0.9 to 2.7 ± 0.6 Hz (means ± SE) without altering the amplitude and the decay time constant of mEPSCs in 25 of 27 lamina IIo neurons. Yohimbine (2 μM, an α2-adrenergic receptor antagonist), but not prazosin (2 μM, an α1-adrenergic receptor antagonist), blocked the inhibitory effect of clonidine on the mEPSCs. Clonidine (1–20 μM, n = 8) also significantly attenuated the peak amplitude of evoked EPSCs in a concentration-dependent manner. The effect of clonidine on evoked EPSCs was abolished in the presence of yohimbine ( n = 5). These data suggest that clonidine inhibits the excitatory synaptic input to lamina IIo neurons through activation of α2-adrenergic receptors located on the glutamatergic afferent terminals. Presynaptic inhibition of glutamate release from primary afferents onto lamina IIoneurons likely plays an important role in the analgesic action produced by activation of the descending noradrenergic system and α2-adrenergic agonists.


Life Sciences ◽  
2006 ◽  
Vol 80 (1) ◽  
pp. 9-16 ◽  
Author(s):  
Md. Joynal Abdin ◽  
Norimitsu Morioka ◽  
Katsuya Morita ◽  
Tomoya Kitayama ◽  
Shigeo Kitayama ◽  
...  

2021 ◽  
pp. 0310057X2110203
Author(s):  
John D Paull ◽  
Michael G Cooper

A number of Charles Darwin’s biographies record the administration of chloroform by Darwin to his wife Emma, during her labour and delivery of her eighth child, Leonard. This occurred on 15 January 1850, a little over two years after James Young Simpson in Edinburgh described the analgesic action of inhaled chloroform. An online search of more than 9000 items of Darwin’s correspondence at Cambridge University and other sources revealed that he was an active proponent and user of chloroform in midwifery, for euthanising animals he studied, as well as in botanical studies of carnivorous plants. He also discovered that the concurrent inhalation of chloroform, during its administration to his wife, alleviated his distressing anxiety which he suffered when present at her earlier confinements.


2015 ◽  
Vol 6 (1) ◽  
pp. 65-68
Author(s):  
Sandeep Kale ◽  
Anand Kalaskar ◽  
Vikram Supugade ◽  
Yogesh Narkhede ◽  
Pradip Kale
Keyword(s):  

1979 ◽  
Vol 51 (6) ◽  
pp. 495-502 ◽  
Author(s):  
J C Yang ◽  
W Crawford Clark ◽  
S H Ngai ◽  
Barry A. Berkowitz ◽  
Sydney Spector
Keyword(s):  

Pain ◽  
1987 ◽  
Vol 30 ◽  
pp. S48 ◽  
Author(s):  
Yu Lin ◽  
T. J. Morrow ◽  
K. L. Casey
Keyword(s):  

Cephalalgia ◽  
1990 ◽  
Vol 10 (5) ◽  
pp. 207-212 ◽  
Author(s):  
Malcolm Skingle ◽  
Phillip J Birch ◽  
Glynnis E Leighton ◽  
Patrick PA Humphrey

The present study attempts to determine whether the novel anti-migraine drug sumatriptan has antinociceptive activity in rodents. Sumatriptan had little or no antinociceptive activity against a range of noxious stimuli and we therefore conclude that it is unlikely that the beneficial effects of the drug in treating migraine are due to a non-specific analgesic action.


Pain ◽  
2003 ◽  
Author(s):  
Michael Hudspith ◽  
Rajesh Munglani
Keyword(s):  

Science ◽  
1949 ◽  
Vol 109 (2829) ◽  
pp. 286-286 ◽  
Author(s):  
D. Slaughter
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document